Merck

JPM recap: Must-reads of the week, from FDA to IPO to M&A and more
Fierce Pharma
Fri, 01/11/19 - 10:25 am
JPMHC 2019
Merck
FDA
M&A
Celgene
Bristol-Myers Squibb
Genevant
IPOs
Eli Lilly
Novartis
GSK
Teva Pharmaceutical
Alexion
Pear Therapeutics
JPM: Why hasn't Merck been making deals? It's not for lack of trying, CEO says
Fierce Pharma
Tue, 01/8/19 - 10:37 am
Merck
Pharma CEOs
Ken Frazier
M&A
JPMHC 2019
Supreme Court hears Merck label preemption case
BioCentury
Tue, 01/8/19 - 12:36 am
Merck
Fosamax
Supreme Court
Pfizer, Merck shares smoking hot in 2018 despite doldrums for overall biopharma sector
Fierce Pharma
Thu, 01/3/19 - 09:46 am
oncology
Merck
Pfizer
Merck bags global rights to NGM NASH drug, plans phase 2b trial
Fierce Biotech
Thu, 01/3/19 - 09:45 am
Merck
NASH
NGM Biopharmaceuticals
type 2 diabetes
clinical trials
MK-3655
Sanofi and Merck Snag FDA Approval for a Six-Disease Combination Vaccine
BioSpace
Thu, 12/27/18 - 10:22 pm
vaccines
FDA
Vaxelis
diphtheria
tetanus
pertussis
polio
hepatitis B
haemophilus influenza type b
Sanofi
Merck
Merck's Keytruda faces delay in first-line approval decision
Biopharma Dive
Fri, 12/21/18 - 10:39 pm
FDA
Keytruda
Merck
metastatic non-small cell lung cancer
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Fierce Pharma
Thu, 12/20/18 - 10:12 am
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
FDA hands AstraZeneca and Merck a snap OK to market Lynparza in frontline ovarian cancer, marking a new standard in treatment
Endpoints
Thu, 12/20/18 - 10:01 am
AstraZeneca
Merck
Lynparza
BRCA-mutated ovarian cancer
FDA
Merck bags adjuvant okay for Keytruda in melanoma
Pharmaforum
Tue, 12/18/18 - 10:13 am
Merck
Europe
Keytruda
melanoma
Merck to Acquire Animal Tracking and Monitoring Company
CP Wire
Fri, 12/14/18 - 12:50 pm
Merck Animal Health
Merck
animal health
M&A
Antelliq
Merck to Acquire Animal Tracking and Monitoring Company
Fri, 12/14/18 - 10:40 am
Merck Animal Health
Merck
Merck taps Roche for Keytruda companion diagnostic
Medtech Dive
Wed, 12/12/18 - 06:41 pm
Merck
Roche
solid tumors
oncology
biomarkers
companion diagnostics
diagnostics
Merck shakes up C-suite as Schechter departs
Biopharma Dive
Wed, 12/12/18 - 12:21 am
Merck
FDA grants breakthrough status to joint Merck-Bayer AI program
Mass Device
Mon, 12/10/18 - 07:17 pm
Merck
Bayer
FDA
breakthrough status
devices
CTEPH
artificial intelligence
Stage Set for Merck’s SCOTUS Case Over Warnings in Labels
RAPS.org
Mon, 12/10/18 - 07:08 pm
Merck
warnings
labeling
Supreme Court
Solicitor general to back Merck at Supreme Court in Fosamax pre-emption case
Fierce Pharma
Tue, 12/4/18 - 07:19 pm
Merck
Fosamax
Supreme Court
Merck increased list prices on Keytruda, Gardasil in November
Biopharma Dive
Thu, 11/29/18 - 11:42 pm
Merck
drug pricing
Keytruda
Gardasil
One more shot at slowing Keytruda’s first-line lung cancer domination
EP Vantage
Wed, 11/28/18 - 10:12 am
Keytruda
Merck
Roche
Tecentriq
Avastin
lung cancer

Pages